Leyla Raiani
Apr 11, 2012

Lung cancer screening save lives at a relatively low cost

Results of a trial conducted by Rush University Medical Center showed that screening with low-dose spiral computed tomography (CT scan) not only reduces lung cancer deaths but would cost insurers less than colorectal, breast and cervical cancer screenings. The core of the cost-benefit calculation was a stage-shift model, in which an intervention -- in this case, lung cancer screening -- shifted the distribution of stages of cancer. The consequence of the stage shift was that more lung cancers were detected at an earlier stage. This leads to treatment costs that are earlier and lower, and to more people cured of or living with cancer. The current study model was designed to estimate the cost and cost-benefit of lung cancer screening for high-risk US smokers and former smokers ages 50 to 64, each of whom had smoked one or more packs of cigarettes a day for at least 30 years. 

Companies
1
Patents
1
0 Comments
Related Articles
Elisabeth Manville
Mar 30, 2012
CT scans identify lung cancers similar in severity to those found through traditional methods
A new study led by researchers at Mount Sinai School of Medicine suggests that computed tomography (CT) scans are more... Read More
Vaccine shows promising survival rates for patients with lung cancer
A long-term follow-up of a clinical trial has shown promising results for patients with non-small cell lung cancer (NSCLC). The... Read More
Technology minimizes CT scan radiation exposure for obese patients
A study from Rensselaer Polytechnic Institute is the first to calculate exactly how much radiation obese patients receive from a... Read More